Molecular Diagnostics Devices And Equipment Market Report 2026

Molecular Diagnostics Devices And Equipment Market Overview

• Molecular Diagnostics Devices And Equipment market size has reached to $27.23 billion in 2025 • Expected to grow to $48.84 billion in 2030 at a compound annual growth rate (CAGR) of 12.7% • Growth Driver: Rising Incidence Of Infectious Diseases Fuels Growth In Molecular Diagnostic Devices Market • Market Trend: Innovative High-Throughput Solutions Redefining Molecular Diagnostics • Asia-Pacific was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Molecular Diagnostics Devices And Equipment Market?

Molecular diagnostics devices are used to diagnose infectious diseases and perform screening by detecting specific sequences in DNA or RNA. It helps doctors prescribe more accurate therapeutic interventions in the early stages of a disease. The main products of molecular diagnostics devices equipment are instruments, reagents, and consumables. A reagent is a substance that is used to cause a chemical reaction. Reagents are used to indicate the presence of another substance. The technologies involved are DNA (deoxyribonucleic acid) sequencing, polymerase chain reaction, isothermal nucleic acid amplification technology, transcription-mediated amplification (TMA), in situ hybridization, microarrays, mass spectrometry, and others (southern blotting, northern blotting, and electrophoresis). The various applications are cancer, pharmacogenomics, genetic testing, infectious disease, prenatal, neurological disease, and cardiovascular disease, which are used by various end-users such as diagnostic laboratories, hospitals, and others (nursing homes, blood banks, point of care).

What Is The Molecular Diagnostics Devices And Equipment Market Growth Forecast?

The molecular diagnostics devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $48.84 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising investments in genomic diagnostics, expansion of decentralized molecular testing, growing adoption of automated sample processing, increasing focus on early-stage disease detection. Major trends in the forecast period include increasing adoption of pcr-based testing platforms, rising use of next-generation sequencing technologies, growing integration of diagnostic software and bioinformatics, expansion of companion diagnostics applications, enhanced focus on early and personalized diagnosis.

Global Molecular Diagnostics Devices And Equipment Market Segmentation

1) By Product: Instruments, Reagents And Consumables, Software 2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies 3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications 4) By End User: Diagnostic laboratories, Hospitals, Other End Users Subsegments: 1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays 2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials 3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation

What Is The Driver Of The Molecular Diagnostics Devices And Equipment Market?

The rising incidence of infectious diseases is expected to propel the growth of the molecular diagnostic devices and equipment market going forward. Infectious diseases refer to illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, that can be transmitted from one individual to another or from animals to humans. The rising incidence of infectious diseases is driven by factors such as antimicrobial resistance, globalization and travel, urbanization, socioeconomic disparities, and an aging population. Molecular diagnostic devices and equipment are essential tools in the detection and management of infectious diseases. For instance, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. Additionally, the incidence rate climbed from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Therefore, the rising incidence of infectious diseases is driving the growth of the molecular diagnostic devices and equipment market.

Key Players In The Global Molecular Diagnostics Devices And Equipment Market

Major companies operating in the molecular diagnostics devices and equipment market are F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di'an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd

Global Molecular Diagnostics Devices And Equipment Market Trends and Insights

Major companies operating in the molecular diagnostics devices and equipment market are developing innovative products such as high-throughput sample-to-result instruments for molecular diagnostics. High-throughput system will be based on ELITech’s proven extraction and assay technology. It will use the same reagents as InGenius and BeGenius. For instance, in April 2023, ELITechGroup, a France-based company engaged in the integrated in-vitro diagnostics launch of a high-throughput sample-to-result instrument for molecular diagnostics. The instrument offers continuous loading of samples and reagents coupled with real random-access capability. The user will be able to run in parallel different PCR reagents, protocols, and sample matrices, with maximum versatility.

What Are Latest Mergers And Acquisitions In The Molecular Diagnostics Devices And Equipment Market?

In February 2023, Sherlock Biosciences, a US-based synthetic biology company, acquired Sense Bio-detection for an undisclosed amount. Through this acquisition, Sherlock aims to advance its CRISPR-based molecular diagnostics capabilities by integrating Sense Bio-detection’s Veros instrument-free rapid test platform and manufacturing expertise. Sense Bio-detection is a UK-based molecular diagnostics company that provides single-use molecular test devices.

Regional Outlook

Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Molecular Diagnostics Devices And Equipment Market?

The molecular diagnostics devices and equipment market consist of sales of thermocycler, single particle mass spectrometers, time-of-flight mass spectrometer (TOF) and others that are used to detect pathogen and infectious diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. This market is segmented into instruments, reagents, and consumables.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.